Regulators Not Adequately Prepared to Manage Risks Posed by Nanotechnology

Three stakeholder groups agree that regulators are not adequately prepared to manage the risks posed by nanotechnology, according to a paper published in the peer-reviewed journal PLOS One. In a survey of nano-scientists and engineers, nano-environmental health and safety scientists, and regulators, researchers at the UCSB Center for Nanotechnology in Society (CNS) and at the University of British Columbia found that those who perceive the risks posed by nanotechnology as "novel" are more likely to believe that regulators are unprepared.

Representatives of regulatory bodies themselves felt most strongly that this was the case. "The people responsible for regulation are the most skeptical about their ability to regulate," said CNS Director and co-author Barbara Herr Harthorn.

"The message is essentially," said first author Christian Beaudrie of the Institute for Resources, Environment, and Sustainability at the University of British Columbia, "the more that risks are seen as new, the less trust survey respondents have in regulatory mechanisms. That is, regulators don't have the tools to do the job adequately."

The authors also believe that when respondents suggested that more stakeholder groups need to share the responsibility of preparing for the potential consequences of nanotechnologies, this indicated a greater "perceived magnitude or complexity of the risk management challenge." Therefore, they assert, not only do regulators feel unprepared, they need input from "a wide range of experts along the nanomaterial life cycle." These include laboratory scientists, businesses, health and environmental groups (NGOs), and government agencies.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.